Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

American Express Beats Expectations with Stellar Earnings in Q1

Daniel Kim Views  

Yonhap News

An American multinational financial services company, American Express (AXP), exceeded consensus with its first-quarter earnings.

American Express’ first quarter revenue for 2024 reached $15.8 billion, a 10.6% increase yearly, and net income rose by 34.2% to $2.4 billion, surpassing market expectations. The total payment amount increased by 5.1% to $419.2 billion, and the total number of issued cards maintained a similar level to the previous quarter, with a 4.9% increase to 140 million cards.

NH Investment & Securities analyst Yoon Yoo Dong stated, “Although revenue from reopening-related sales decreased, other consumption expanded,” and “thanks to the significant influx of younger generations, as the company aimed for 60% of new customers to be from the MZ generation.”

After the earnings announcement, the stock price rose 6%. Analysts believe this is due to the active new card business and the company maintaining its guidance for 2024 despite unfavorable economic conditions.

Recently, competitors Visa and Mastercard announced they would reduce merchant fees by at least four bps each after a 20-year lawsuit, causing their stock prices to drop. According to media reports, this amount is estimated to reach around $30 billion over the next five years.

Analyst Yoon Yoo Dong stated, “The company has fewer merchants compared to others, which has relatively protected its stock price from this issue,” and “If annual good performance is backed up, a continuous outperform is expected.”

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[BUSINESS] Latest Stories

  • Honda's NSX Returns: A 1,000-Horsepower Electric Rival to Lexus LFR
  • Honda’s S7 Electric SUV: A Major Player in the Race for EV Dominance
  • Lamborghini's First EV: A 2,000-Horsepower Beast Built for Speed and Emotion
  • Ford Revives Classic Design with the 2025 Bronco Heritage Edition
  • ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible
  • Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

You May Also Like

  • 1
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 2
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 3
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 4
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

  • 5
    This Celebrity Lost 7kg—and Her Diet Includes ...

    LIFESTYLE 

Popular Now

  • 1
    Red vs. White Wine: Which Is Riskier for Cancer? New Study Has the Answer

    LIFESTYLE&nbsp

  • 2
    Breakfast vs. Dinner: Which Meal Should You Load Up On for Better Health?

    LIFESTYLE&nbsp

  • 3
    Eat More Greens—But Skip the Fake Stuff, Scientists Warn

    LIFESTYLE&nbsp

  • 4
    Veggies vs. IBD: New Research Says the Right Diet Might Be a Game-Changer

    LIFESTYLE&nbsp

  • 5
    Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown

    LIFESTYLE&nbsp

Must-Reads

  • 1
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 2
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 3
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 4
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

  • 5
    This Celebrity Lost 7kg—and Her Diet Includes ...

    LIFESTYLE 

Popular Now

  • 1
    Red vs. White Wine: Which Is Riskier for Cancer? New Study Has the Answer

    LIFESTYLE 

  • 2
    Breakfast vs. Dinner: Which Meal Should You Load Up On for Better Health?

    LIFESTYLE 

  • 3
    Eat More Greens—But Skip the Fake Stuff, Scientists Warn

    LIFESTYLE 

  • 4
    Veggies vs. IBD: New Research Says the Right Diet Might Be a Game-Changer

    LIFESTYLE 

  • 5
    Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown

    LIFESTYLE